Novartis Investigative Site — Jena, Thuringia

Public research footprint of Novartis Investigative Site, compiled from the ClinicalTrials.gov public registry.

101

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Primary Immune Thrombocytopenia (ITP) · Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive · Leukemia, Myelogenous, Chronic, BCR-ABL Positive · Cardiovascular Disease and Lipoprotein(a)

Recently updated registry entries

NCT05344469 — A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing… (Recruiting)
NCT07288359 — Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients… (Recruiting)
NCT06830720 — A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Novartis Investigative Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.